@NICEComms

Official feed of NICE - National Institute for Health and Care Excellence. We produce evidence-based health and social care guidance. Tweets by the comms team.

 London and Manchester, UK
nice.org.uk
Joined October 2009
  • Tweets17.3K
  • Following1.1K
  • Followers236K
9.3KMedia
Sepsis caused 133,484 hospital admissions in England in 2024/25, and can be fatal within hours. A new Modern Service Framework aims to change that, with NICE evidence helping the NHS treat sepsis faster and more consistently. 🔗 orlo.uk/8PVJP @NHSEngland
2
9
1
19
2,164
We’ve brought together 25 clinical guidelines and 16 quality standards on women’s health in one place, making evidence easier to find, use and act on Explore how this work supports the government’s Women’s Health Strategy 👇 orlo.uk/OgJ7e
NICE graphic titled ‘Putting evidence at the heart of women’s health’. Text explains how NICE’s women’s health topic suite supports the Government’s Women’s Health Strategy. Alongside is a photograph of a person in conversation.

ALT NICE graphic titled ‘Putting evidence at the heart of women’s health’. Text explains how NICE’s women’s health topic suite supports the Government’s Women’s Health Strategy. Alongside is a photograph of a person in conversation.

1
716
Developing a medicine? Get early, joined-up advice from @MHRAgovuk and NICE. Our integrated scientific advice service is helping companies understand evidence requirements earlier, and prepare for the aligned pathway. Read how it's working in practice: orlo.uk/JPoYc
NICE and MHRA graphic promoting a joint advice service with one enquiry form, one advice meeting, one report and one payment.

ALT NICE and MHRA graphic promoting a joint advice service with one enquiry form, one advice meeting, one report and one payment.

874
On #WorldEBHCDay, we're highlighting how AI can support better health and care when it's used safely, transparently and based on robust evidence. Read how NICE's AI delivery plan will support responsible adoption across the NHS 👇 orlo.uk/gNnx0
1
848
From blood-based biomarkers to AI-powered tools, discover how 9 innovations are being tested in the NHS to speed up diagnosis as part of UKRI’s Dementia Challenge: orlo.uk/hOP96 #Dementia #HealthTech
Graphic with NICE Advice logo and the following text: 92% of people diagnosed within 18 weeks by 2029. That's the goal of UK Research and Innovation's Dementia Challenge.

ALT Graphic with NICE Advice logo and the following text: 92% of people diagnosed within 18 weeks by 2029. That's the goal of UK Research and Innovation's Dementia Challenge.

1
4
1,000
We've published final guidance recommending trastuzumab deruxtecan as a treatment option for adults with HER2-positive unresectable or metastatic breast cancer after 1 or more anti-HER2 treatments. Learn more: orlo.uk/0WNF8
1
3
1,131
This #MenopauseAwarenessDay, explore our guideline on identifying and managing menopause: orlo.uk/SSKs8 It supports personalised care and informed treatment choices, including information on treatment options when HRT is not suitable. #NICEWomensHealth
NICE-branded graphic with the headline "Menopause affects everyone differently". Supporting text explains that NICE guidance supports personalised care, informed treatment choices and discussions about treatment options. A photo shows a person holding a mug while seated in conversation.

ALT NICE-branded graphic with the headline "Menopause affects everyone differently". Supporting text explains that NICE guidance supports personalised care, informed treatment choices and discussions about treatment options. A photo shows a person holding a mug while seated in conversation.

1
6
1,608
We've recently expanded treatment, including recommending a non-hormonal treatment for moderate to severe hot flushes and night sweats when HRT is not suitable: orlo.uk/SYu7g #NICEWomensHealth
1
607
Hundreds of thousands of people with type 2 diabetes could benefit from a new weekly insulin injection after NICE recommended insulin efsitora alfa today. For people eligible, this could reduce injections from 365 a year to just 52. Find out more: nice.org.uk/guidance/TA1200
1
1
8
1,644
Just over 500 adults with desmoid tumours could benefit from a new NHS treatment option: orlo.uk/uZWCx NICE has recommended nirogacestat, the first targeted treatment for this rare condition. Clinical trials show it increases the time before the condition gets worse.
4
2,364
We're consulting on proposed updates to our guideline on suspected sepsis in pregnancy. The draft incorporates the national Maternity Early Warning Score (MEWS) to help support consistent care. Read more: orlo.uk/zTpxb
NICE graphic for a draft guideline consultation on suspected sepsis in pregnancy, incorporating the national Maternity Early Warning Score (MEWS). A pregnant person is pictured in a healthcare setting.

ALT NICE graphic for a draft guideline consultation on suspected sepsis in pregnancy, incorporating the national Maternity Early Warning Score (MEWS). A pregnant person is pictured in a healthcare setting.

2
5
1,306
NICE has published a new process for funding variation requests, used when the NHS requires more time to implement a recommended treatment. The changes will help ensure timely and consistent decision making: orlo.uk/GLNpG
1
5
2,097
🎙️ Talking General Practice podcast 🎙️ NICE's new chief medical officer, Windsor GP Dr Adrian Hayter, speaks to GPonline editor Emma Bower in this week's episode. @NICEComms Full episode: gponline.com/podcast-gp-nice…
2
1
820
Hundreds of people with a rare blood condition that causes severe itching, usually starting in early childhood, could be set to benefit after we recommended a new treatment today. Find out more about maralixibat: nice.org.uk/guidance/indevel…
1
4
1,358
We welcome the government's acceptance of the AI Commission's recommendations. At NICE, we're helping create the evidence, standards and guidance needed to support the safe and effective adoption of AI technologies that benefit patients and the NHS. nice.org.uk/news/blogs/harne…

Harnessing the potential of AI to bring real benefits for patients

nice.org.uk
MHRAgovuk
@MHRAgovukOct 6
📢 12,000+ patients, clinicians and members of the public helped shape the AI Commission’s recommendations on AI in healthcare Today, Government accepted all 44 recommendations for safe AI regulation. Read more: brnw.ch/21x6bSu
10
5
7
2,704
How is NICE preparing for the future of healthcare?🎙️ In our latest #NICEtalks podcast episode, we explore the research shaping decisions on AI, digital health, new medicines and more. Listen now: nice.org.uk/news/podcasts/ho…

How NICE prepares for the healthcare of tomorrow

nice.org.uk
1
4
3
2,050
Hundreds of people with a very rare genetic disorder that leads to extremely high levels of a type of fat in the blood are set to benefit after NICE recommended two new treatments in final draft guidance today. Learn more about olezarsen and plozasiran: nice.org.uk/guidance/indevel…
1
1,891
Around 1,750 people with multiple myeloma could benefit from a new treatment option. NICE final guidance recommends daratumumab with bortezomib, lenalidomide and dexamethasone for untreated multiple myeloma in people eligible for a stem cell transplant nice.org.uk/guidance/ta1195?…
1
3
2,318
The @MHRAgovuk-NICE aligned pathway is gathering pace, with the first medicine expected to complete its journey later this year. Read our update on how same time decisions on licencing and value, and integrated scientific advice, are working in practice: nice.org.uk/news/blogs/mhra-…
Graphic showing blister-packed capsules alongside NICE and MHRA logos. Text states that 90 topics have been scheduled to the MHRA-NICE aligned pathway across 49 therapeutic areas.

ALT Graphic showing blister-packed capsules alongside NICE and MHRA logos. Text states that 90 topics have been scheduled to the MHRA-NICE aligned pathway across 49 therapeutic areas.

2
5
1,995
NICE has published final draft guidance recommending two existing Enhertu indications for routine NHS use in England. Both treatments are already available on the NHS through the Cancer Drugs Fund since 2021 and 2023: nice.org.uk/guidance/indevel…
A healthcare consultation taking place. Overlaid text reads: Treatment recommendation for HER2+ breast cancer - Enhertu will now be routinely available on the NHS in England for around 1,100 adults with advanced HER2+ breast cancer

ALT A healthcare consultation taking place. Overlaid text reads: Treatment recommendation for HER2+ breast cancer - Enhertu will now be routinely available on the NHS in England for around 1,100 adults with advanced HER2+ breast cancer

1
1
4
2,523
Load more